Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction

Drug and Alcohol Dependence

Volumn 123, Issue SUPPL.1, 2012, Pages

  Sweitzer, Maggie M ^a,b   Donny, Eric C ^a,b   Hariri, Ahmad R ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Dopamine; Genetics; Impulsivity; Neuroimaging; Nicotine; Reward

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; BEHAVIOR GENETICS; BOLD FUNCTIONAL MAGNETIC RESONANCE IMAGING; BOLD SIGNAL; BRAIN FUNCTION; CARBON MONOXIDE BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; DRD2 GENE; DRT1 GENE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IMPULSIVENESS; MALE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; REWARD; SIGNAL TRANSDUCTION; SMOKING CESSATION; SOCIAL BEHAVIOR; TOBACCO DEPENDENCE;

ADULT; BASAL GANGLIA; BEHAVIOR, ADDICTIVE; GENETIC VARIATION; HUMANS; IMPULSIVE BEHAVIOR; INDIVIDUALITY; MALE; NEURAL PATHWAYS; NEUROIMAGING; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; TOBACCO USE DISORDER;

EID: 84862837834     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.01.017     Document Type: Review

References (115)

1. Acheson A., Vincent A.S., Sorocco K.H., Lovallo W.R. Greater discounting of delayed rewards in young adults with family histories of alcohol and drug use disorders: studies from the Oklahoma family health patterns project. Alcohol. Clin. Exp. Res. 2011, 35:1607-1613.
2. Agrawal A., Lynskey M.T. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008, 103:1069-1081.
3. Alessi S.M., Petry N.M. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav. Process. 2003, 64:345-354.
4. Allen T.J., Moeller F.G., Rhoades H.M., Cherek D.R. Impulsivity and history of drug dependence. Drug Alcohol Depend. 1998, 50:137-145.
5. Anker J.J., Perry J.L., Gliddon L.A., Carroll M.E. Impulsivity predicts the escalation of cocaine self-administration in rats. Pharmacol. Biochem. Behav. 2009, 93:343-348.
6. Anthony J.C., Warner L.A., Kessler R.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 1994, 2:244-268.
7. Arinami T., Gao M., Hamaguchi H., Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum. Mol. Genet. 1997, 6:577-582.
8. Audrain-McGovern J., Rodriguez D., Epstein L.H., Cuevas J., Rodgers K., Wileyto E.P. Does delay discounting play an etiological role in smoking or is it a consequence of smoking?. Drug Alcohol Depend. 2009, 103:99-106.
9. Bannon M.J., Michelhaugh S.K., Wang J., Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur. Neuropsychopharmacol. 2001, 11:449-455.
10. Barr R.S., Pizzagalli D.A., Culhane M.A., Goff D.C., Evins A.E. A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence. Biol. Psychiatry 2008, 63:1061-1065.
11. Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch. Gen. Psychiatry 1987, 44:211-218.
12. Benoit-Marand M., Borrelli E., Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 2001, 21:9134-9141.
13. Bickel W.K., Marsch L.A. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 2001, 96:73-86.
14. Bigos K.L., Pollock B.G., Aizenstein H.J., Fisher P.M., Bies R.R., Hariri A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225.
15. Brown S.M., Manuck S.B., Flory J.D., Hariri A.R. Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion 2006, 6:239-245.
16. Chaudhri N., Caggiula A.R., Donny E.C., Palmatier M.I., Liu X., Sved A.F. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl.) 2006, 184:353-366.
17. Cheon K.A., Ryu Y.H., Kim J.W., Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur. Neuropsychopharmacol. 2005, 15:95-101.
18. Cloninger C.R., Bohman M., Sigvardsson S. Inheritance of alcohol abuse: cross-fostering analysis of adopted men. Arch. Gen. Psychiatry 1981, 38:861-868.
19. Coffey S.F., Gudleski G.D., Saladin M.E., Brady K.T. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp. Clin. Psychopharmacol. 2003, 11:18-25.
20. Cryan J.F., Hoyer D., Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry 2003, 54:49-58.
21. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
22. Dawkins L., Powell J.H., West R., Powell J., Pickering A. A double-blind placebo controlled experimental study of nicotine: I - effects on incentive motivation. Psychopharmacology (Berl.) 2006, 189:355-367.
23. de Wit H., Flory J.D., Acheson A., McLoskey M., Manuck S.B. IQ and nonplanning impulsivity are independently associated with delay discounting in middle-aged adults. Pers. Individ. Dif. 2007, 42:111-121.
24. Diergaarde L., Pattij T., Poortvliet I., Hogenboom F., de Vries W., Schoffelmeer A.N., De Vries T.J. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol. Psychiatry 2008, 63:301-308.
25. Dillon D.G., Bogdan R., Fagerness J., Holmes A.J., Perlis R.H., Pizzagalli D.A. Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum. Brain Mapp. 2010, 31:210-221.
26. Donny E.C., Chaudhri N., Caggiula A.R., Evans-Martin F.F., Booth S., Gharib M.A., Clements L.A., Sved A.F. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl.) 2003, 169:68-76.
27. Donny E.C., Dierker L.C. The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend. 2007, 89:93-96.
28. Dreher J.C., Kohn P., Kolachana B., Weinberger D.R., Berman K.F. Variation in dopamine genes influences responsivity of the human reward system. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:617-622.
29. Epping-Jordan M.P., Watkins S.S., Koob G.F., Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998, 393:76-79.
30. Fisher P.M., Meltzer C.C., Ziolko S.K., Price J.C., Moses-Kolko E.L., Berga S.L., Hariri A.R. Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat. Neurosci, 2006, 9:1362-1363.
31. Forbes E.E., Brown S.M., Kimak M., Ferrell R.E., Manuck S.B., Hariri A.R. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol. Psychiatry 2009, 14:60-70.
32. Garavan H., Pankiewicz J., Bloom A., Cho J.K., Sperry L., Ross T.J., Salmeron B.J., Risinger R., Kelley D., Stein E.A. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am. J. Psychiatry 2000, 157:1789-1798.
33. Green L., Myerson J. A discounting framework for choice with delayed and probabilistic rewards. Psychol. Bull. 2004, 130:769-792.
34. Hahn J., Kullmann P.H., Horn J.P., Levitan E.S. D2 autoreceptors chronically enhance dopamine neuron pacemaker activity. J. Neurosci. 2006, 26:5240-5247.
35. Han C., McGue M.K., Iacono W.G. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction 1999, 94:981-993.
36. Hariri A.R. The neurobiology of individual differences in complex behavioral traits. Annu. Rev. Neurosci. 2009, 32:225-247.
37. Hariri A.R., Brown S.M., Williamson D.E., Flory J.D., de Wit H., Manuck S.B. Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J. Neurosci. 2006, 26:13213-13217.
38. Hariri A.R., Gorka A., Hyde L.W., Kimak M., Halder I., Ducci F., Ferrell R.E., Goldman D., Manuck S.B. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry 2009, 66:9-16.
39. Hariri A.R., Mattay V.S., Tessitore A., Fera F., Smith W.G., Weinberger D.R. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 2002, 27:1036-1040.
40. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
41. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., Lee K.S., Linnoila M., Weinberger D.R. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139.
42. Heinz A., Siessmeier T., Wrase J., Hermann D., Klein S., Grusser S.M., Flor H., Braus D.F., Buchholz H.G., Grunder G., Schreckenberger M., Smolka M.N., Rosch F., Mann K., Bartenstein P. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am. J. Psychiatry 2004, 161:1783-1789.
43. Heinz A., Wrase J., Kahnt T., Beck A., Bromand Z., Grusser S.M., Kienast T., Smolka M.N., Flor H., Mann K. Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcohol. Clin. Exp. Res. 2007, 31:1138-1147.
44. Horn N.R., Dolan M., Elliott R., Deakin J.F.W., Woodruff P.W.R. Response inhibition and impulsivity: an fMRI study. Neuropsychologia 2003, 41:1959-1966.
45. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 2006, 29:565-598.
46. Johnstone T., Somerville L.H., Alexander A.L., Oakes T.R., Davidson R.J., Kalin N.H., Whalen P.J. Stability of amygdala BOLD response to fearful faces over multiple scan sessions. Neuroimage 2005, 25:1112-1123.
47. Jomphe C., Lemelin P.L., Okano H., Kobayashi K., Trudeau L.E. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons. Eur. J. Neurosci. 2006, 24:2789-2800.
48. Kable J.W., Glimcher P.W. The neural correlates of subjective value during intertemporal choice. Nat. Neurosci. 2007, 10:1625-1633.
49. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 2005, 162:1403-1413.
50. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry 2003, 160:687-695.
51. Kim D.K., Lim S.W., Lee S., Sohn S.E., Kim S., Hahn C.G., Carroll B.J. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 2000, 11:215-219.
52. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. Gen. 1999, 128:78-87.
53. Knutson B., Rick S., Wimmer G.E., Prelec D., Loewenstein G. Neural predictors of purchases. Neuron 2007, 53:147-156.
54. Kollins S.H. Delay discounting is associated with substance use in college students. Addict. Behav. 2003, 28:1167-1173.
55. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52-58.
56. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
57. Koob G.F., Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 2005, 8:1442-1444.
58. Koob G.F., Le Moal M. Addiction and the brain antireward system. Annu. Rev. Psychol. 2008, 59:29-53.
59. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2009, 35:217-238.
60. Lee B.T., Ham B.J. Serotonergic genes and amygdala activity in response to negative affective facial stimuli in Korean women. Genes Brain Behav. 2008, 7:899-905.
61. Logue A.W. Self-control: Waiting Until Tomorrow for What You Want Today 1995, Prentice-Hall, Englewood Cliffs, NJ.
62. MacKillop J., Kahler C.W. Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend. 2009, 104:197-203.
63. Madden G.J., Petry N.M., Badger G.J., Bickel W.K. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp. Clin. Psychopharmacol. 1997, 5:256-262.
64. Manuck S.B., Brown S.M., Forbes E.E., Hariri A.R. Temporal stability of individual differences in amygdala reactivity. Am. J. Psychiatry 2007, 164:1613-1614.
65. Markou A., Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 1991, 4:17-26.
66. Martin-Soelch C., Missimer J., Leenders K.L., Schultz W. Neural activity related to the processing of increasing monetary reward in smokers and nonsmokers. Eur. J. Neurosci. 2003, 18:680-688.
67. Martinez D., Gelernter J., Abi-Dargham A., van Dyck C.H., Kegeles L., Innis R.B., Laruelle M. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001, 24:553-560.
68. McClure S.M., Laibson D.I., Loewenstein G., Cohen J.D. Separate neural systems value immediate and delayed monetary rewards. Science 2004, 306:503-507.
69. Menon M., Jensen J., Vitcu I., Graff-Guerrero A., Crawley A., Smith M.A., Kapur S. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol. Psychiatry 2007, 62:765-772.
70. Michelhaugh S.K., Fiskerstrand C., Lovejoy E., Bannon M.J., Quinn J.P. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J. Neurochem. 2001, 79:1033-1038.
71. Mill J., Asherson P., Browes C., D'Souza U., Craig I. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am. J. Med. Genet. 2002, 114:975-979.
72. Mill J., Asherson P., Craig I., D'Souza U.M. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet. 2005, 6:3.
73. Mitchell S.H. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl.) 1999, 146:455-464.
74. Mitchell S.H. The genetic basis of delay discounting and its genetic relationship to alcohol dependence. Behav. Process. 2011, 87:10-17.
75. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. Am. J. Psychiatry 2001, 158:1783-1793.
76. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol. Psychiatry 2008, 63:852-857.
77. O'Doherty J.P. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr. Opin. Neurobiol. 2004, 14:769-776.
78. Olausson P., Jentsch J.D., Taylor J.R. Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology 2003, 28:1264-1271.
79. Olausson P., Jentsch J.D., Taylor J.R. Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl.) 2004, 171:173-178.
80. Perkins K.A., Lerman C., Coddington S.B., Jetton C., Karelitz J.L., Scott J.A., Wilson A.S. Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl.) 2008, 200:529-544.
81. Petry N.M. Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend. 2001, 63:29-38.
82. Petry N.M., Kirby K.N., Kranzler H.R. Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects. J. Stud. Alcohol. 2002, 63:83-90.
83. Pine A., Shiner T., Seymour B., Dolan R.J. Dopamine, time, and impulsivity in humans. J. Neurosci. 2010, 30:8888-8896.
84. Powell J., Dawkins L., Davis R.E. Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol. Psychiatry 2002, 51:151-163.
85. Powell J.H., Pickering A.D., Dawkins L., West R., Powell J.F. Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. Addict. Behav. 2004, 29:1407-1426.
86. Reynolds B., Richards J.B., Horn K., Karraker K. Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav. Process. 2004, 65:35-42.
87. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
88. Rose J.E., Behm F.M., Salley A.N., Bates J.E., Coleman R.E., Hawk T.C., Turkington T.G. Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 2007, 32:2441-2452.
89. Schulteis G., Markou A., Cole M., Koob G.F. Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:5880-5884.
90. Schultz W. Getting formal with dopamine and reward. Neuron 2002, 36:241-263.
91. Sesack S.R., Hawrylak V.A., Guido M.A., Levey A.I. Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv. Pharmacol. 1998, 42:171-174.
92. Shiffman S., Waters A., Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob. Res. 2004, 6:327-348.
93. Sibley D.R., Monsma F.J., Shen Y. Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 1993, 35:391-415.
94. Siessmeier T., Kienast T., Wrase J., Larsen J.L., Braus D.F., Smolka M.N., Buchholz H.G., Schreckenberger M., Rosch F., Cumming P., Mann K., Bartenstein P., Heinz A. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. Eur. J. Neurosci. 2006, 24:305-313.
95. Stulz N., Gallop R., Lutz W., Wrenn G.L., Crits-Christoph P. Examining differential effects of psychosocial treatments for cocaine dependence: an application of latent trajectory analyses. Drug Alcohol Depend. 2009, 106:164-172.
96. Sweitzer M.M., Donny E.C., Dierker L.C., Flory J.D., Manuck S.B. Delay discounting and smoking: association with the Fagerstrom Test for Nicotine Dependence but not cigarettes smoked per day. Nicotine Tob. Res. 2008, 10:1571-1575.
97. Tessitore A., Hariri A.R., Fera F., Smith W.G., Chase T.N., Hyde T.M., Weinberger D.R., Mattay V.S. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J. Neurosci. 2002, 22:9099-9103.
98. van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., Baldwin R.M., Innis R.B., Gelernter J. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J. Nucl. Med. 2005, 46:745-751.
99. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet. 2005, 6:55.
100. Viding E., Williamson D.E., Hariri A.R. Developmental imaging genetics: challenges and promises for translational research. Dev. Psychopathol. 2006, 18:877-892.
101. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 2001, 158:2015-2021.
102. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 2000, 10:318-325.
103. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004, 47(Suppl. 1):3-13.
104. Volkow N.D., Hitzemann R., Wang G.J., Fowler J.S., Burr G., Pascani K., Dewey S.L., Wolf A.P. Decreased brain metabolism in neurologically intact healthy alcoholics. Am. J. Psychiatry 1992, 149:1016-1022.
105. Volkow N.D., Hitzemann R., Wang G.J., Fowler J.S., Wolf A.P., Dewey S.L., Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992, 11:184-190.
106. Volkow N.D., Wang G.J., Begleiter H., Porjesz B., Fowler J.S., Telang F., Wong C., Ma Y., Logan J., Goldstein R., Alexoff D., Thanos P.K. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch. Gen. Psychiatry 2006, 63:999-1008.
107. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
108. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Jayne M., Ma Y., Pradhan K., Wong C. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J. Neurosci. 2007, 27:12700-12706.
109. Vuchinich R.E., Simpson C.A. Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp. Clin. Psychopharmacol. 1998, 6:292-305.
110. Weaver, M.T., Sweitzer, M., Coddington, S., Sheppard, J., Verdecchia, N., Caggiula, A.R., Sved, A.F., Donny, E.C. Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats. Nicotine Tob. Res., [Epub ahead of print accessed on Jan 19 2012].
111. Wrase J., Schlagenhauf F., Kienast T., Wustenberg T., Bermpohl F., Kahnt T., Beck A., Strohle A., Juckel G., Knutson B., Heinz A. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 2007, 35:787-794.
112. Yacubian J., Sommer T., Schroeder K., Glascher J., Kalisch R., Leuenberger B., Braus D.F., Buchel C. Gene-gene interaction associated with neural reward sensitivity. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8125-8130.
113. Yarkoni T. Big correlations in little studies: Inflated fMRI correlations reflect low statistical power - commentary on Vul et al. (2009). Perspect. Psychol. Sci. 2009, 4:294-298.
114. Yoshida K., Ito K., Sato K., Takahashi H., Kamata M., Higuchi H., Shimizu T., Itoh K., Inoue K., Tezuka T., Suzuki T., Ohkubo T., Sugawara K., Otani K. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:383-386.
115. Zijlstra F., Veltman D.J., Booij J., van den Brink W., Franken I.H. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend. 2009, 99:183-192.